Evid Invest
Holders — by stockHoldings — by fund

First Turn Management, LLC

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001993440

$753.0M

disclosed book value

38

positions

5.8%

largest position share

Positions, as of 2026-09-30

top 38 of 38 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1ELVNENLIVEN THERAPEUTICS INC958,700$43.9M5.8%
2GHGUARDANT HEALTH INC219,304$39.1M5.2%
3ABVXABIVAX SA384,592$38.1M5.1%
4ROIVROIVANT SCIENCES LTD985,583$36.0M4.8%
5UTHRUNITED THERAPEUTICS CORP DEL60,064$32.5M4.3%
6VRDNVIRIDIAN THERAPEUTICS INC1.5M$31.4M4.2%
7AXSMAXSOME THERAPEUTICS INC.162,407$29.9M4%
8INSMINSMED INC245,726$28.0M3.7%
9CELCCELCUITY INC329,101$26.2M3.5%
10CRLCHARLES RIV LABS INTL INC86,801$25.6M3.4%
11CYTKCYTOKINETICS INC357,945$23.6M3.1%
12BBIOBRIDGEBIO PHARMA INC354,371$23.3M3.1%
13PRAXPRAXIS PRECISION MEDICINES I78,806$23.0M3%
14ORICORIC PHARMACEUTICALS INC1.6M$21.2M2.8%
15RGENREPLIGEN CORP108,436$20.8M2.8%
16TNGXTANGO THERAPEUTICS INC766,860$19.1M2.5%
17RVMDREVOLUTION MEDICINES INC92,316$18.9M2.5%
18INBXINHIBRX BIOSCIENCES INC171,512$17.2M2.3%
19NAMSNEWAMSTERDAM PHARMA COMPANY702,396$17.1M2.3%
20MANEVERADERMICS INC136,718$16.6M2.2%
21COGTCOGENT BIOSCIENCES INC514,976$16.5M2.2%
22DNTHDIANTHUS THERAPEUTICS INC178,573$15.7M2.1%
23PVLAPALVELLA THERAPEUTICS INC NE109,871$15.2M2%
24RYTMRHYTHM PHARMACEUTICALS INC157,603$15.0M2%
25RCUSARCUS BIOSCIENCES INC577,693$14.9M2%
26ARWRARROWHEAD PHARMACEUTICALS IN222,649$14.6M1.9%
27IRONDISC MEDICINE INC220,666$14.4M1.9%
28ERASERASCA INC913,452$13.4M1.8%
29GRALGRAIL INC93,727$13.1M1.7%
30KYMRKYMERA THERAPEUTICS INC113,299$12.7M1.7%
31ASNDASCENDIS PHARMA A/S54,594$12.4M1.7%
32QUREUNIQURE NV465,474$11.2M1.5%
33XENEXENON PHARMACEUTICALS INC297,060$11.0M1.5%
34SYRESPYRE THERAPEUTICS INC102,541$9.1M1.2%
35SMMTSUMMIT THERAPEUTICS INC501,724$8.5M1.1%
36DFTXDEFINIUM THERAPEUTICS INC216,531$8.2M1.1%
37PCVXVAXCYTE INC137,534$7.8M1%
38HNGEHINGE HEALTH INC75,448$7.3M1%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.